A research team funded by the National Institutes of Health (NIH) has developed a medication that shows promise in treating acute and chronic pain.
Treatment for chronic pain still relies heavily on opioids. While effective, they are highly addictive and potentially deadly ...
A new compound provides the pain-relieving properties of cannabis - without the mind-bending side effects. It may be an ...
A new compound provides the pain-relieving properties of cannabis - without the mind-bending side effects. It may be an ...
A new compound provides the pain-relieving properties of cannabis - without the mind-bending side effects. It may be an ...
U.S. researchers said Wednesday they have reproduced the pain-relieving effects of cannabis with a synthesized compound that ...
A newly published study found that among drug users who experience chronic pain, daily cannabis use was linked to a higher ...
LTG-001, a selective inhibitor for treatment of acute pain, was granted Fast Track designation by the Food and Drug Administration (FDA).
In two randomized clinical trials evaluating pain control following abdominoplasty and bunionectomy, Journavx demonstrated ...
In my years as a nurse working in a drug detox unit, I’ve witnessed both the crushing grip of addiction and the grueling ...
1d
Vertex Pharmaceuticals Incorporated ( NASDAQ: VRTX) TD Cowen 45th Annual Health Care Conference Transcript March 3, 2025 3:10 PM ET David Altshuler - Executive Vice President, Global Research and CSO ...
Despite not differentiating itself from placebo, the Texas-based company said it plans to push pilavapadin into Phase III ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback